Trademark: 79350511
Word
INDIMIX
Status
Pending
Status Code
641
Status Date
Tuesday, January 9, 2024
Serial Number
79350511
Mark Type
4000
Filing Date
Tuesday, June 21, 2022

Trademark Owner History

Classifications
5 Pharmaceutical medical preparations for treating infections; veterinary medical products, namely, vaccines; medical products for medical healthcare purposes, namely, reagents for medical use; diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes, namely, diagnostic agents for medical and veterinary in-vitro diagnostics; diagnostic agents for medical and veterinary purposes, namely, biological diagnostic agents for testing diseases in cattle, pigs, and other animals; kits comprised of reagents for medical use, oligonucleotides, monoclonal antibodies, in-vitro diagnostic reagents and control reagents all for medical purposes, sold as a unit for medical purposes; diagnostic test kits comprised of testing equipment in the nature of biomolecules, namely, oligonucleotides, buffer substances, such as salts and proteins, primers and probes for DNA and RNA biomarker testing and DNA and RNA infectious disease testing for medical, veterinary, and dental purposes; products for medical and veterinary medical purposes, namely, diagnostic preparations for sample preparation, for modification and manipulation of cells and for labelling, for separation, for isolation, for purification, for amplification and for analysis of natural and synthetic biopolymers, in the nature of nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products, reagents for medical use, for sample preparation, and for modification and manipulation of cells, all for medical use; in vitro diagnostic preparations for medical purposes; diagnostic disease testing kits comprised of medical diagnostic reagents, in the nature of biomolecules, namely, oligonucleotides, buffer substances, such as salts and proteins, primers and probes for DNA and RNA biomarker testing and DNA and RNA disease testing for medical, veterinary, and dental purposes; buffers for medical and veterinary purposes; diagnostic disease testing kits comprised of reagents, oligonucleotides, nucleotides, buffers, in-vitro diagnostic preparations, and control reagents all for medical and veterinary use, sold as a unit for medical and veterinary use
1 Chemical, biochemical and biotechnological reagents for industrial and scientific purposes and laboratory analysis, other than in vivo use and other than for medical or veterinary purposes; Chemical, biochemical and biotechnological substances for industrial and scientific purposes and laboratory analysis, other than in vivo use and other than for medical or veterinary purposes; Biochemicals for scientific and research use, namely, for sample preparation, modification and manipulation of cells and for labeling, isolation, purification, amplification and analysis of natural and synthetic biopolymers, in the nature of nucleotides, buffer substances such as salts, proteins for industrial use, macromolecules and biologically active substances, none of the foregoing for medical or veterinary use; biochemicals, namely, small molecular chemicals for scientific or research use; laboratory chemicals, namely, small molecular chemicals used for the detection of nucleic acids in cell and tissue analysis for in vitro diagnostic use; chemicals and biochemical preparations used in industry, in particular, chemical and biochemical substances for molecular biological, biochemical and immunological laboratory testing and analysis, other than for medical or veterinary purposes; kits comprising biochemical reagents for scientific and research use, namely, for sample preparation, modification and manipulation of samples and cells and for labeling, separation, isolation, purification, especially amplification and analysis of natural and synthetic biopolymers, in particular, nucleic acids for laboratory use, oligonucleotides, proteins for industrial use, macromolecules and biologically active substances, none of the foregoing for medical or veterinary use; kits for multiplex polymerase chain reaction (PCR) tests comprised of DNA primers for amplifying DNA and RNA loci

Trademark Events
Mar 18, 2024
Notification Of Possible Opposition - Processed By Ib
Feb 28, 2024
Notification Of Possible Opposition Sent To Ib
Feb 28, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 9, 2024
Notification Of Non-Final Action E-Mailed
Jan 9, 2024
Non-Final Action E-Mailed
Jan 9, 2024
Non-Final Action Written
Dec 6, 2023
Teas/Email Correspondence Entered
Dec 6, 2023
Correspondence Received In Law Office
Dec 6, 2023
Teas Response To Office Action Received
Jun 26, 2023
Refusal Processed By Ib
Jun 6, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jun 6, 2023
Refusal Processed By Mpu
Apr 9, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Apr 8, 2023
Non-Final Action Written
Apr 1, 2023
Assigned To Examiner
Sep 27, 2022
Application Filing Receipt Mailed
Sep 23, 2022
New Application Office Supplied Data Entered
Sep 22, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24